In Search of the Holy Grail
<b>Part Two of a Two-Part Article.</b> In our article that appeared in last month's issue, we discussed the special rule contained in Section 382(l)(5) with respect to the use of net operating losses by a company that has restructured under the protection of the bankruptcy court. Where the stock, debt and claims against a bankrupt company are traded, companies execute lock up agreements with their stockholders or request orders from the bankruptcy court to restrict trading in the stock, debt or claims so as to protect its net operating loss carry forwards. Often, out of an excess of caution, the orders requested have been overly broad and have disrupted trading in such debt and claims. On Nov. 22, 2004, The Bond Market Association and The Loan Syndications and Trading Association announced that in a joint effort they had developed a model NOL order to address these disruptions. Part Two discusses the results.
Features
The Devil in the Details
In theory, a borrower's issuance of junior secured debt is a boon for its senior secured lender. The borrower obtains additional capital, and the claims of the junior lender against shared collateral, since "subordinated," don't diminish the senior lender's prospects for repayment. In practice, however, a senior secured lender should view proposed junior secured financing skeptically because the existence of such debt can become highly problematic for the senior lender. The key to protecting the senior lender lies in properly negotiating and documenting the intercreditor agreement with the junior lender to eliminate, or at least minimize the myriad of ways in which the junior lender's rights may, in practice, limit -- or even trump -- those of the senior lender.
The Bankruptcy Hotline
Recent rulings of interest to you and your practice.
World Trade Center Attack Held to Constitute Two Occurrences
On Dec. 6, 2004, a New York federal jury determined that the 9/11 attacks on the World Trade Center involved two "occurrences" under policies issued to leaseholder Larry Silverstein. As a result, Silverstein could get up to $1.1 billion more than if the attacks had constituted a single occurrence.
Features
Media & Communications Corner <b>Media Relations: A Look Back and A Look Forward</b>
It continues to be a great pleasure for the media relations professionals at Jaffe Associates to contribute our viewpoints on the publicity issues and trends that all of you face each day. Since becoming regular columnists for <i>Marketing the Law Firm</i>, we have covered a number of topics that we hope have been educational and even inspirational. Here, we take a look back at these columns and tell you some of next year's topics.
Features
A Haven For Straight Talk <b>New Year's Resolution: Kicking the Ad-diction</b>
I have a confession to make: I am occasionally wrong. There. I've said it, and I can move on. I've heard that admitting you have a problem is the first step towards a cure, and so I'm well on the road to recovery. Now it's time for our industry to admit it has a problem and take a similar step towards wellness ' Advertising.
Features
The Year in Review: Our Look Back and Look Forward
The year 2004 has been my first full year as Editor-in-Chief of this publication. While there have been challenges, there have also been some rewards. So, sit back, relax and enjoy the first half of 2004 as I present to you selected highlights of <i>Marketing the Law Firm</i> for the months January through June.
Features
Intellectual Capital Value at Risk
In previous articles we have imagined a dialogue between Treasury and IP professionals. The IP professionals have done most of the talking so far; from their point of view, this conversational flow makes perfect sense. The world of patents and trademarks is exotic, specialized and counterintuitive, having undergone substantial change in governing law and predominant management technique since 1990. In contrast, one would expect the management of mere cash flows to be a mature discipline. What can Treasury tell us about how to manage IP? "Buy-low and sell high"?
The Use of Demonstratives in Patent Litigation
A picture is worth a thousand words — or perhaps more — when the concept being described is complicated, abstract or unfamiliar. By its very nature, the technology associated with a patent demands the use of visual and other aids in order to be understandable by a juror, judge, or other trier of fact. Not surprisingly then, demonstratives are essential tools in patent litigation to illustrate or contradict fact and expert witness testimony, as teaching aids in <i>Markman</i> hearings, and in opening and closing arguments. A number of legal and practical considerations should be kept in mind when preparing and using demonstrative aids.
Features
The Strategy Toolbox
Researchers and technology managers may not deal with IP every day like IP professionals do, but they are still exposed to all sorts of patent strategy tools, especially when they are attempting to develop a patent strategy for a business. The advertisements for these tools typically imply that life would be so much simpler if only they used the vendor's latest and greatest tool. Many of these tools are very useful; however, most tools also have limitations. Having a framework from which to evaluate these tools is therefore helpful to researchers and managers.
Need Help?
- Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
- Need other assistance? email Customer Service or call 1-877-256-2472.
MOST POPULAR STORIES
- Meet the Lawyer Working on Inclusion Rider LanguageAt the Oscars in March, Best Actress winner Frances McDormand made “inclusion rider” go viral. But Kalpana Kotagal, a partner at Cohen Milstein Sellers & Toll had already worked for months to write the language for such provisions. Kotagal was developing legal language for contract provisions that Hollywood's elite could use to require studios and other partners to employ diverse workers on set.Read More ›
- Law Firms and the Rise of HospitalityThe law firm office cannot remain unchanged, as if frozen in time set to some date prior to the onset of pandemic, when the terms and meaning have all changed. In fact, the office must now provide benefits or an experience the lawyers and staff cannot get at home.Read More ›
- From the PTO to the FDA: What to Consider When Branding Clinical TrialsThe legal implications of branding generally arise initially for companies during the process of selecting a company name and any initial product or service names. For drug development companies, however, careful consideration should also be paid to the implications of branding a clinical trial.Read More ›
- Disconnect Between In-House and Outside Counsel'Disconnect Between In-House and Outside Counsel is a continuation of the discussion of client expectations and the disconnect that often occurs. And although the outside attorneys should be pursuing how inside-counsel actually think, inside counsel should make an effort to impart this information without waiting to be asked.Read More ›